Redox-dependent protein S-glutathionylation governs azacitidine sensitivity and resistance in AML

Dušan Nemes1, Michaela Myšáková1, Lubomír Minařík2

  • 1BIOCEV, First Faculty of Medicine, Charles University, Vestec, 25250, Czech Republic; Faculty of Science, Charles University, Prague, 128 00, Czech Republic.

Redox Biology
|December 13, 2025
PubMed

Insights

Drug resistance in acute myeloid leukemia (AML) involves altered redox metabolism. Restoring protein S-glutathionylation sensitizes resistant AML cells to azacitidine therapy.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Disrupted redox metabolism is characteristic of drug-resistant cancers, particularly acute myeloid leukemia (AML).
  • Understanding protein redox signaling in AML drug resistance is crucial for developing effective therapies.
  • Azacitidine (AZA) is a hypomethylating agent used in AML treatment, but resistance limits its efficacy.

Purpose of the Study:

  • To investigate the role of protein redox signaling in azacitidine (AZA) resistance in acute myeloid leukemia (AML).
  • To identify mechanisms underlying redox homeostasis disruption and restoration in AZA-resistant AML.
  • To explore therapeutic strategies for overcoming AZA resistance by targeting redox pathways.

Main Methods:

  • Comprehensive mass spectrometry-based redox and quantitative proteomic profiling.
  • Analysis of AML cell lines and patient samples sensitive or resistant to azacitidine (AZA).
  • Assessment of glyoxalase system and DNA damage response pathways.

Main Results:

  • Azacitidine (AZA) disrupts redox homeostasis, inactivating the glyoxalase system and DNA damage response, leading to cell death in sensitive AML.
  • AZA resistance is linked to a redox reset with elevated glutathione and reduced protein S-glutathionylation.
  • AZA failed to induce protein oxidation in key pathways in resistant AML cells and patient samples.
  • Pharmacological inhibition of glutathione synthesis restored protein S-glutathionylation and AZA sensitivity in resistant AML cells.

Conclusions:

  • AZA resistance in AML involves a failure to disrupt redox homeostasis, characterized by elevated glutathione levels.
  • Targeting glutathione synthesis can restore protein S-glutathionylation and overcome AZA resistance in AML.
  • These findings highlight redox signaling as a therapeutic vulnerability in AZA-resistant AML.

Related Concept Videos

Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
294
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
779